Literature DB >> 12373087

A rare, in-frame BCR-ABL fusion (e13a3) in a patient with an aggressive chronic myeloid leukaemia.

Ivone B Otazú1, María Belén Rivero, Renata Olício, Augusto Pinto, Ilana Zalcberg, Héctor N Seuánez.   

Abstract

We have identified a rare BCR-ABL chimaeric gene with multiplex and nested RT-PCR in a patient with an unusually aggressive chronic myeloid leukaemia. cDNA sequencing showed an in-frame rearrangement with a breakpoint in BCR exon e13 (b2) and fusion with ABL exon 3 following skipping of the entire ABL exon a2. These data confirm the heterogeneity of breakpoints in BCR-ABL rearrangements. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12373087     DOI: 10.1159/000064701

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  3 in total

1.  A chronic myeloid leukemia patient with atypical karyotype and BCR-ABL e13a3 transcript caused by complex chromosome rearrangement.

Authors:  Masayoshi Masuko; Tatsuo Furukawa; Takashi Abe; Reiko Wada; Soichi Maruyama; Toshiki Kitajima; Yasuhiko Shibasaki; Ken Toba; Masahiko Okada; Yoshifusa Aizawa
Journal:  Int J Hematol       Date:  2009-06-30       Impact factor: 2.490

2.  Molecular response to imatinib in chronic myeloid leukaemia with a variant e13a3 BCR-ABL1 fusion.

Authors:  Sarah L McCarron; Stephen E Langabeer; Karen Bolger; Karl Haslam; Mireille Crampe; Johanna Kelly; Ruth Morrell
Journal:  Med Oncol       Date:  2015-01-13       Impact factor: 3.064

Review 3.  A variant transcript, e1a3, of the minor BCR-ABL fusion gene in acute lymphoblastic leukemia: case report and review of the literature.

Authors:  Shinya Fujisawa; Satoki Nakamura; Kensuke Naito; Masahide Kobayashi; Kazunori Ohnishi
Journal:  Int J Hematol       Date:  2008-02-06       Impact factor: 2.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.